share_log

华领医药-B(02552.HK)8月29日举行董事会会议考虑及通过中期业绩

Hualing Pharmaceuticals-B (02552.HK) held a board of directors meeting on August 29 to consider and approve the mid-term performance.

Gelonghui Finance ·  Aug 19, 2024 16:32

China State-Owned Enterprise Hualing Pharmaceutical (02552.HK) announced that the board of directors meeting will be held on Thursday, August 29, 2024 to consider and approve the interim performance of the group ending on June 30, 2024, and related announcements, as well as to deal with other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment